Last reviewed · How we verify

NCT07270484: ReHyb

Rehabilitation Based on Hybrid Neuroprosthesis

Completed NA Last updated 22 December 2025
What this trial tests

NA trial testing ReHyb-HPP in Post Stroke in 24 participants. Completed in 24 May 2024.

Timeline
12 February 2024
Primary endpoint
24 May 2024
24 May 2024

Quick facts

Lead sponsorVilla Beretta Rehabilitation Center
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposedevice feasibility
Enrollment24
Start date12 February 2024
Primary completion24 May 2024
Estimated completion24 May 2024
Sites2 locations across Italy, Germany

Drugs / interventions tested

Conditions studied

Sponsor

Villa Beretta Rehabilitation Center

Who can join

18 and older, any sex, with Post Stroke. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is a pilot, multi-center, prospective, and open study to test feasibility, functionality and usability of a device defined as a hybrid neuroprosthesis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Post Stroke

Currently open trials in the same condition.

Other Villa Beretta Rehabilitation Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07270484.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing